1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-47-1-1
1998-01-01
2022-06-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/47/1/medmicro-47-1-1.html?itemId=/content/journal/jmm/10.1099/00222615-47-1-1&mimeType=html&fmt=ahah

References

  1. De Clercq E. Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses. Rev Med Virol 1995; 5:149–164
    [Google Scholar]
  2. Field A. K., Biron K. K. “The end of innocence” revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev 1994; 7:1–13
    [Google Scholar]
  3. De Clercq E. Broad-spectrum anti-DNA virus and antiretrovirus activity of phosphonyl-methoxyalkylpurines and-pyrimidines. Biochem Pharmacol 1991; 42:963–972
    [Google Scholar]
  4. Cihlar T., Chen M. S. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol Pharmacol 1996; 50:1502–1510
    [Google Scholar]
  5. Balzarini J., Nave J. F., Becker M. A., Tatibana M., De Clercq E. Kinetic properties of adenine nucleotide analogues against purified 5-phosphoribosyl-l-pyrophosphate synthetases from E. coli, rat liver and human erythrocytes. Nucleosides Nucleotides 1995; 14:1861–1871
    [Google Scholar]
  6. Merta A., Votruba I., Jindrich J. Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine by AMP (dAMP) kinase from L1210. Biochem Pharmacol 1992; 44:2067–2077
    [Google Scholar]
  7. Naesens L., Snoeck R., Andrei G., Balzarini J., Neyts J., De Clercq E. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chem Chemother 1997; 8:1–23
    [Google Scholar]
  8. Kramata P., Votruba I., Otová B., Holý A. Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases α, and ε. Mol Pharmacol 1996; 49:1005–1011
    [Google Scholar]
  9. Cihlar T., Chen M. S. Incorporation of selected nucleoside phosphonates and anti-human immunodeficiency virus nucleotide analogues into DNA by human DNA polymerases a, β and γ. Antiviral Chem Chemother 1997; 8:187–195
    [Google Scholar]
  10. Xiong X., Smith J. L., Chen M. S. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob Agents Chemother 1997; 41:594–599
    [Google Scholar]
  11. De Clercq E. Therapeutic potential of HPMPC as an antiviral drug. Rev Med Virol 1993; 3:85–96
    [Google Scholar]
  12. De Clercq E. Therapeutic potential of cidofovir (HPMPC, Vistide™) for the treatment of DNA virus (i.e. herpes-, papova-, pox-and adenovirus) infections. Verh K Acad Geneeskd Belg 1996; 58:19–49
    [Google Scholar]
  13. Kedes D. H., Ganem D. Sensitivity of Kaposi’s sarcoma-associated herpesvirus replication to antiviral drugs. J Clin Invest 1997; 99:2082–2086
    [Google Scholar]
  14. Reymen D., Naesens L., Balzarini J., Holy A., Dvoráková H., De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 1995; 28:343–357
    [Google Scholar]
  15. Takahashi K., Suzuki M., Iwata Y., Shigeta S., Yamanishi K., De Clercq E. Selective activity of various nucleoside and nucleotide analogues against human herpesvirus 6 and 7. Antiviral Chem Chemother 1997; 8:24–31
    [Google Scholar]
  16. Andrei G., Snoeck R., Vandeputte M., De Clercq E. Activities of various compounds against murine and primate polyoma-viruses. Antimicrob Agents Chemother 1997; 41:587–593
    [Google Scholar]
  17. De Oliveira C. B. R., Stevenson D., LaBree L., McDonnell P. J., Trousdale M. D. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res 1996; 31:165–172
    [Google Scholar]
  18. Tsai C. C., Follis K. E., Sabo A. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995; 270:1197–1199
    [Google Scholar]
  19. Van Rompay K. K. A., Cherrington J. M., Marthas M. L. 9-[2-(phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. Antimicrob Agents Chemother 1996; 40:2586–2591
    [Google Scholar]
  20. Tsai C. C., Follis K. E., Beck T. W., Sabo A., Bischofberger N., Dailey P. J. Effects of (R)-9-(2-phosphonylmethoxypropyl)ade-nine monotherapy on chronic SIV infection in macaques. AIDS Res Hum Retroviruses 1997; 13:707–712
    [Google Scholar]
  21. Lalezari J. P., Stagg R. J., Kuppermann B. D. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997; 126:257–263
    [Google Scholar]
  22. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. Ann Intern Med 1997; 126:264–274
    [Google Scholar]
  23. Van Cutsem E., Snoeck R., Van Ranst M. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-l-(3-hydroxy-2-phos-phonylmethoxypropyl)cytosine. J Med Virol 1995; 45:230–235
    [Google Scholar]
  24. De Clercq E. Development of resistance of human immunodeficiency virus (HIV) to anti-HIV agents: how to prevent the problem?. Int J Antimicrob Agents 1997; 9:21–36
    [Google Scholar]
  25. Cherrington J. M., Mulato A. S., Fuller M. D., Chen M. S. Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro. Antimicrob Agents Chemother 1996; 40:2212–2216
    [Google Scholar]
  26. Cherrington J. M. Human cytomegalovirus: resistance profile of cidofovir. Int Antiviral News 1997; 5:91–92
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-47-1-1
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error